Semaglutide Journey : Description of her decision to start semaglutide, including initial hesitations, the management of side effects, and the lifestyle adjustments made to accommodate the medication
This hormone is released in response to food intake and works by enhancing insulin secretion from the pancreas in a glucose-dependent manner, meaning it stimulates insulin release only when blood glucose levels are high
Medical weight loss may be appropriate for adults who: Have a BMI of 30 or higher Have a BMI of 27 or higher with weight-related health conditions Struggle to lose weight through diet and exercise alone Want physician-supervised treatment Need help controlling cravings and hunger The most successful programs combine medication with: Nutritional guidance Physical activity Lifestyle coaching Ongoing monitoring Cost Considerations: Semaglutide vs Tirzepatide Cost can significantly influence treatment decisions
Cardiovascular risk reduction: Approved for adults with established cardiovascular disease who are also overweight or obese
In the SURMOUNT-1 trial, adults without diabetes on tirzepatide lost an average of 15-22% of body weight over 72 weeks, depending on dose
In SURMOUNT-1, adults with obesity or overweight without diabetes experienced substantial weight reduction over 72 weeks
